Author

Emily Sabbagh

At a comprehensive cancer center in New Haven, Connecticut, Emily Sabbagh, PharmD, BCOP, serves as an oncology clinical pharmacist. Over the past 10 years, Sabbagh has reviewed chemotherapy regimens, monitored drug interactions, and counseled patients who are beginning targeted therapies or biologics. She received her doctor of pharmacy degree from the University of North Carolina at Chapel Hill and works alongside oncologists to help manage medication side effects throughout treatment.

What Is Disitamab Vedotin & How Does It Work for Cancer?
How Long Does Olaparib Work and Why It Stops
Streptonigrin: An Anticancer Agent With High Toxicity
How Vinblastine Works as a Chemotherapy Drug
Why Is 5FU Given Over 46 Hours?
Prexasertib: Cancer Trials, How It Works, and Side Effects
Pelabresib: A New Treatment for Myelofibrosis
Etoposide Mechanism of Action: How It Fights Cancer
Aumolertinib: A Targeted Cancer Therapy Explained
Quisinostat: Uses, Side Effects, and Mechanism
What Is Batimastat and Why Was It Discontinued?
Doxorubicin’s Mechanism of Action on Cancer Cells
What Are Glutamine Inhibitors and How Do They Work?
Ribociclib vs. Abemaciclib: A Comparison of Cancer Drugs
What Is Mitomycin Chemotherapy and How Does It Work?
The Mechanism of Action of Cytarabine
What Is Marimastat and What Was It Investigated For?
Avapritinib for Mastocytosis: A Targeted Therapy
Ribociclib’s Mechanism of Action in Cancer Therapy